Core Laboratories Reports Q4 2025 Earnings: Revenue $138.3 M, EPS Beat Estimates

CLB
February 05, 2026

Core Laboratories Inc. reported fourth‑quarter 2025 results that surpassed consensus expectations, with revenue of $138.26 million and a non‑GAAP earnings per share of $0.21, a $0.01 (5%) beat over the $0.20 consensus estimate.

Revenue rose 3% sequentially to $138.3 million and 7% year‑over‑year, driven by a 5% sequential increase in the Reservoir Description segment (revenue $92.3 million) and an 8% year‑over‑year gain in the Production Enhancement segment (revenue $46 million). The Reservoir Description segment also generated $12.7 million in operating income, up 9% sequentially, while Production Enhancement produced $3 million, with margins expanding 300 basis points year‑over‑year.

Operating income for the quarter was $15.8 million, giving an operating margin of just over 11%. The margin contracted 100 basis points sequentially and 80 basis points year‑over‑year, largely due to geopolitical sanctions that limited revenue in the Reservoir Description segment, pass‑through revenue on a collaborative program, and higher labor costs. Full‑year operating income ex‑items fell 10% and full‑year non‑GAAP EPS ex‑items declined 14% compared with 2024, reflecting the margin compression seen in the quarter.

Management guided for Q1 2026 with revenue of $124–$130 million, operating income of $9.7–$12.2 million (about 9% margin) and EPS of $0.11–$0.15. The guidance signals a cautious outlook amid expected seasonal softness in the U.S. land market, while the company’s asset‑light model continues to support free cash flow and shareholder returns.

CEO Larry Bruno highlighted that strong international demand for Core’s proprietary technologies offset a seasonally soft U.S. land market, underscoring the company’s pricing power and resilience in offshore and deep‑water projects. The company celebrated its 90th anniversary, noting that its long‑standing commitment to shareholder returns and a low leverage profile remain core pillars of its strategy.

The market reacted mildly positively, with the stock rising 0.17% on the day of the announcement and peaking at +3.5% during the session, reflecting investor approval of the earnings beat and the company’s outlook for continued international growth.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.